ZA888461B - Azelastine-containing medicaments for application in the nose and/or at the eye - Google Patents

Azelastine-containing medicaments for application in the nose and/or at the eye

Info

Publication number: ZA888461B
Authority: ZA; South Africa
Prior art keywords: azelastine; eye; nose; application; containing medicaments
Prior art date: 1987-11-13

Application number

ZA888461A

Other languages

English (en)

Inventor

Helmut Hettche

Hettche Helmut

Original Assignee

Asta Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-11-13

Filing date

1988-11-11

Publication date

1989-08-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6340483&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA888461(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1988-11-11 Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag

1989-08-30 Publication of ZA888461B publication Critical patent/ZA888461B/xx

Links

MBUVEWMHONZEQD-UHFFFAOYSA-N Azeptin Chemical compound C1CN(C)CCCC1N1C(=O)C2=CC=CC=C2C(CC=2C=CC(Cl)=CC=2)=N1 MBUVEWMHONZEQD-UHFFFAOYSA-N 0.000 title abstract 3
229960004574 azelastine Drugs 0.000 title abstract 3
239000003814 drug Substances 0.000 title abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Ophthalmology & Optometry (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

ZA888461A 1987-11-13 1988-11-11 Azelastine-containing medicaments for application in the nose and/or at the eye ZA888461B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE3738681		1987-11-13

Publications (1)

Publication Number	Publication Date
ZA888461B true ZA888461B (en)	1989-08-30

Family

ID=6340483

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA888461A ZA888461B (en)	1987-11-13	1988-11-11	Azelastine-containing medicaments for application in the nose and/or at the eye

Country Status (15)

Country	Link
US (1)	US5164194A (pt)
EP (1)	EP0316633B1 (pt)
JP (3)	JP2911460B2 (pt)
AT (1)	ATE84968T1 (pt)
AU (1)	AU613107B2 (pt)
CA (1)	CA1319322C (pt)
DE (1)	DE3877904D1 (pt)
DK (1)	DK174928B1 (pt)
ES (1)	ES2053678T3 (pt)
GR (1)	GR3007202T3 (pt)
IE (1)	IE61562B1 (pt)
NL (1)	NL990011I1 (pt)
PT (1)	PT88985B (pt)
YU (1)	YU46988B (pt)
ZA (1)	ZA888461B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE68347T1 (de) *	1987-01-17	1991-11-15	Asta Pharma Ag	Synergistische kombination von azelastin und theophyllin oder azelastin und beta-mimetika.
US5897858A (en)	1994-02-03	1999-04-27	Schering-Plough Healthcare Products, Inc.	Nasal spray compositions exhibiting increased retention in the nasal cavity
US5976573A (en)	1996-07-03	1999-11-02	Rorer Pharmaceutical Products Inc.	Aqueous-based pharmaceutical composition
JP4138910B2 (ja) *	1997-07-02	2008-08-27	帝國製薬株式会社	経皮吸収性が良好で且つ皮膚刺激性の少ない塩酸アゼラスチン含有経皮製剤
JP2005281315A (ja) *	1997-07-02	2005-10-13	Aventis Pharmaceuticals Holdings Inc	水性薬理組成物
US6080783A (en) *	1998-09-01	2000-06-27	Gum Tech International, Inc.	Method and composition for delivering zinc to the nasal membrane
KR20020050275A (ko) *	1999-11-11	2002-06-26	다케다 야쿠힌 고교 가부시키가이샤	융합 피리다진 유도체를 함유하는 점비제
US7833549B2 (en)	2000-01-19	2010-11-16	Mannkind Corporation	Dry powder formulations of antihistamine for nasal administration
DE10007203A1 (de)	2000-02-17	2001-08-23	Asta Medica Ag	Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
DE20009841U1 (de) *	2000-05-31	2001-10-25	Phyt-Immun GmbH, 66424 Homburg	Nasensalbe auf Basis von Vaselin
JP3450805B2 (ja) *	2000-08-08	2003-09-29	わかもと製薬株式会社	水性医薬組成物
AU2002236781A1 (en) *	2001-01-18	2002-07-30	Medpointe Healthcare Inc.	Treatment for snoring
US7977376B2 (en)	2001-06-27	2011-07-12	Novartis Ag	Olopatadine formulations for topical nasal administration
TWI231759B (en) *	2001-06-27	2005-05-01	Alcon Inc	Olopatadine formulations for topical administration
US6641799B2 (en)	2002-04-03	2003-11-04	Nos Spray, Inc.	Nasal spray for decongesting nasal passages
GB2389530B (en)	2002-06-14	2007-01-10	Cipla Ltd	Pharmaceutical compositions
ES2393864T3 (es) *	2002-08-30	2012-12-28	Nycomed Gmbh	El uso de la asociación de ciclesonida y antihistaminas para el tratamiento de rinitis alérgica
EP1651190B1 (en) *	2003-08-05	2012-09-19	3M Innovative Properties Company	Formulations containing an immune response modifier
US20070020299A1 (en)	2003-12-31	2007-01-25	Pipkin James D	Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
RU2006132043A (ru) *	2004-02-06	2008-03-20	МЕДА Фарма ГмбХ унд Ко.КГ (DE)	Комбинация и фармацевтический препарат для лечения ринита
US8758816B2 (en) *	2004-11-24	2014-06-24	Meda Pharmaceuticals Inc.	Compositions comprising azelastine and methods of use thereof
DK2377557T3 (en)	2004-11-24	2017-02-06	Meda Pharmaceuticals Inc	Compositions comprising azelastine and methods for its use
US20070020330A1 (en)	2004-11-24	2007-01-25	Medpointe Healthcare Inc.	Compositions comprising azelastine and methods of use thereof
GB2423711B (en)	2005-10-24	2007-02-14	Fortune Apex Dev Ltd	Method for preparing a pharmaceutical composition with enhanced mucoadhesion
US7378082B1 (en) *	2007-11-05	2008-05-27	Inspire Pharmaceuticals, Inc.	Method for treating allergic rhinitis without adverse effects
ES2493641T3 (es) *	2007-06-28	2014-09-12	Cydex Pharmaceuticals, Inc.	Administración nasal de soluciones acuosas de corticosteroides
WO2009086055A1 (en) *	2007-12-21	2009-07-09	Schering-Plough Healthcare Products, Inc.	Enhancing photostabilization of oxymetazoline
WO2010025236A1 (en) *	2008-08-27	2010-03-04	Alexander Goldin	Composition and method for treating colds
KR101261230B1 (ko)	2010-11-29	2013-05-07	한림제약(주)	모메타손 푸로에이트 및 아젤라스틴 염산염을 포함하는 비내 투여용 약학 조성물
CN105307655B (zh)	2013-03-13	2019-05-03	弗拉特利发现实验室有限责任公司	哒嗪酮化合物及其用于制备治疗囊肿状纤维化的药物的应用
EP3061501A1 (en)	2015-02-27	2016-08-31	Rottapharm Ltd.	Composition for the treatment of acne
EP3117825A1 (en)	2015-07-16	2017-01-18	Rottapharm S.p.A.	Oral formulation comprising berberine and morus alba extract
KR102192384B1 (ko) *	2018-12-17	2020-12-17	최연서	광원이 회전 가능한 cob형 led 조명 장치
JP2023530166A (ja)	2020-06-15	2023-07-13	アルケム・ラボラトリーズ・リミテッド	アルカフタジンとコルチコステロイドの組み合わせ
US20240173331A1 (en)	2021-04-01	2024-05-30	Alkem Laboratories Limited	Nasal compositions comprising alcaftadine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US158564A (en) *		1875-01-12		Improvement in medicine-droppers
US2119643A (en) *	1934-11-07	1938-06-07	Mendl Viktor	Pressure-operated diffuser of toilet-liquids
US2136940A (en) *	1936-07-02	1938-11-15	Aromel Corp	Atomizer
US2457024A (en) *	1945-02-13	1948-12-21	Arp Claus	Collapsible tube holder
US2995308A (en) *	1958-09-23	1961-08-08	American Home Prod	Jet stream dispenser
CH572914A5 (pt) *	1971-01-22	1976-02-27	Asta Werke Ag Chem Fab
US3813384A (en) *	1972-01-17	1974-05-28	Asta Werke Ag Chem Fab	Basically substituted benzyl phthalazone derivatives,acid salts thereof and process for the production thereof
DE3530793A1 (de) *	1984-09-14	1986-03-27	Asta-Werke Ag Chemische Fabrik, 4800 Bielefeld	Substituierte benzylphthalazinon-derivate
DE3575135D1 (de) *	1984-09-14	1990-02-08	Asta Pharma Ag	Substituierte benzylphthalazinon-derivate.
US4769369A (en) *	1986-11-14	1988-09-06	Pennwalt Corporation	Anti-allergy 1(2H)-phthalazinones

1988
- 1988-10-27 EP EP88117902A patent/EP0316633B1/de not_active Revoked
- 1988-10-27 ES ES88117902T patent/ES2053678T3/es not_active Expired - Lifetime
- 1988-10-27 DE DE8888117902T patent/DE3877904D1/de not_active Revoked
- 1988-10-27 AT AT88117902T patent/ATE84968T1/de active
- 1988-11-10 CA CA000582817A patent/CA1319322C/en not_active Expired - Lifetime
- 1988-11-10 JP JP63282639A patent/JP2911460B2/ja not_active Expired - Lifetime
- 1988-11-10 YU YU209288A patent/YU46988B/sh unknown
- 1988-11-11 PT PT88985A patent/PT88985B/pt not_active IP Right Cessation
- 1988-11-11 IE IE340388A patent/IE61562B1/en not_active IP Right Cessation
- 1988-11-11 DK DK198806301A patent/DK174928B1/da not_active IP Right Cessation
- 1988-11-11 AU AU25063/88A patent/AU613107B2/en not_active Expired
- 1988-11-11 ZA ZA888461A patent/ZA888461B/xx unknown
1990
- 1990-07-12 US US07/551,644 patent/US5164194A/en not_active Expired - Lifetime
1993
- 1993-03-02 GR GR930400447T patent/GR3007202T3/el unknown
1997
- 1997-12-26 JP JP9359963A patent/JP2956029B2/ja not_active Expired - Lifetime
1999
- 1999-01-28 JP JP01995599A patent/JP3207816B2/ja not_active Expired - Lifetime
- 1999-04-01 NL NL990011C patent/NL990011I1/nl unknown

Also Published As

Publication number	Publication date
NL990011I1 (nl)	1999-07-01
IE883403L (en)	1989-05-13
JP3207816B2 (ja)	2001-09-10
US5164194A (en)	1992-11-17
DK630188A (da)	1989-05-14
JP2956029B2 (ja)	1999-10-04
EP0316633B1 (de)	1993-01-27
GR3007202T3 (pt)	1993-07-30
IE61562B1 (en)	1994-11-16
JPH01153639A (ja)	1989-06-15
DK630188D0 (da)	1988-11-11
JPH11349484A (ja)	1999-12-21
DK174928B1 (da)	2004-03-01
JP2911460B2 (ja)	1999-06-23
EP0316633A1 (de)	1989-05-24
ES2053678T3 (es)	1994-08-01
PT88985B (pt)	1993-01-29
CA1319322C (en)	1993-06-22
DE3877904D1 (de)	1993-03-11
YU46988B (sh)	1994-09-09
AU2506388A (en)	1989-05-18
ATE84968T1 (de)	1993-02-15
YU209288A (en)	1990-04-30
JPH10182464A (ja)	1998-07-07
AU613107B2 (en)	1991-07-25
PT88985A (pt)	1988-12-01

Publication	Publication Date	Title
ZA888461B (en)	1989-08-30	Azelastine-containing medicaments for application in the nose and/or at the eye
NL990012I1 (nl)	1999-07-01	Geneesmiddelen die salmeterol en fluticason bevatten.
ES2077530A1 (es)	1995-11-16	Procedimiento para la preparacion de productos farmaceuticos para curar enfermedades tumorales.
IL99699A0 (en)	1992-08-18	Method of treating or preventing type 1 diabetes by oral administration of insulin
FI19991893A (fi)	1999-09-06	Säädellysti budesonidia vapauttava oraalisesti annettava koostumus ja budesonidin käyttö
ATE92762T1 (de)	1993-08-15	Medikamente.
AU1935788A (en)	1989-03-09	A process for producing an administration and/or dosage form for medically active ingredients of drugs
BR9401199A (pt)	1994-10-18	Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento.
GR3015014T3 (en)	1995-05-31	Compositions for topical administration containing fluticasone propionate and oxiconazole or its salts.
MC2025A1 (fr)	1990-04-25	Medicament contenant de l'azelastine et capable de liberer celle-ci de facon controlee
PH27446A (en)	1993-07-02	Compound with gastric acid inhibitory effect
EP0302714A3 (en)	1990-02-14	Pharmaceutical composition for treatment of bone-wasting diseases
ES2059312T3 (es)	1994-11-16	Medicamento que puede administrarse por via nasal, procedimiento para su preparacion y su aplicacion.
GR3017855T3 (en)	1996-01-31	Use of lithium in the treatment or prophylaxis of Molluscum contagiosum.
GR3018365T3 (en)	1996-03-31	Use of 15-deoxyspergualine as a medicament.
WO1986006960A3 (en)	1987-01-29	Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
SE9101341D0 (sv)	1991-05-03	New medicinal use
GB2019720A (en)	1979-11-07	S-adenosyl-L-homocysteine and salts thereof for use in therapy
SE8105500L (sv)	1982-10-08	Psykotropa lekemedel
MY111155A (en)	1999-09-30	Medicaments
DK157782C (da)	1990-08-13	Farmaceutisk praeparat med differentieret afgivelse og indeholdende pinacidil som aktiv bestanddel